市場調查報告書

心臟輔助裝置市場 - 產業分析及市場預測(2017年∼2022年)

Cardiac Assist Devices Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 390616
出版日期 內容資訊 英文 120 Pages
商品交期: 2-3個工作天內
價格
心臟輔助裝置市場 - 產業分析及市場預測(2017年∼2022年) Cardiac Assist Devices Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年02月01日內容資訊: 英文 120 Pages
簡介

心臟輔助裝置,是改善心臟幫浦效率,支援維持身體整體血流的電子機械設備。心室輔助裝置,以幫浦將血液傳送到身體整體再現心臟功能,使心臟恢復正常的功能。

本報告提供全球心臟輔助裝置市場調查,整體市場趨勢,各產品、地區的詳細趨勢,市場成長的影響要素分析,競爭情形,主要企業簡介等,總括性彙整。

目錄

第1章 簡介

  • 調查成果
  • 市場定義
  • 規模的單位
  • 基本貨幣
  • 檢討及預測期間
  • 一般的調查的前提條件

第2章 調查方法

  • 簡介
  • 分析方法論
  • 計量經濟學的預測模式
  • 調查的前提條件

第3章 摘要整理

第4章 主要推論

第5章 市場概要與產業趨勢

  • 目前市場方案
  • 心臟輔助裝置的應用
  • 技術概要
  • 新發展
  • 產業的價值鏈分析
  • 產品生命週期分析
  • 產品基準
  • 投資分析
  • 波特的五力分析
    • 供應商談判力
    • 消費者談判力
    • 新加入廠商的威脅
    • 產品與服務的替代品的威脅
    • 產業內的競爭

第6章 成長要素,阻礙因素,機會分析

  • 市場成長要素
    • 新產品的銷售
    • 高齡人口
    • 增加的病的流行
    • 心臟器官捐贈的不足
    • 有利的償付方針
  • 市場阻礙因素
    • 嚴格的法規指南
    • 心臟移植
  • 市場機會
    • VAD的技術進步

第7章 市場區隔

  • 簡介
  • 各產品類型市場區隔
    • 大主動脈內氣球幫浦 市場
    • 全人工心臟
    • 心室輔助裝置
    • 循環支援設備

第8章 各地區市場市場區隔

  • 北美
    • 簡介
    • 南北美洲
    • 加拿大
    • 墨西哥
  • 歐洲
    • 簡介
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪地那維亞
    • 荷比盧三國
    • 其他
  • 亞太地區(APAC)
    • 簡介
    • 中國
    • 日本
    • 印度
    • 澳洲和紐西蘭
    • 韓國
    • 其他
  • 中東、北非
    • 簡介
    • GCC
    • 埃及
    • 其他
  • 南美
    • 簡介
    • 巴西
    • 阿根廷
    • 其他

第9章 競爭情形

  • 合併收購分析
  • 新產品的銷售
  • 協定,競爭,聯盟

第10章 主要供應商分析

  • Abiomed Inc.
  • Berlin Heart GmbH
  • Bioheart, Inc.
  • BiVacor Pty Ltd.
  • Braile Biomedica Ltd.
  • Calon Cardio-Technology Ltd.
  • Cardiac Assist, Inc.
  • CardioBridge GmbH
  • CardioKinetix, Inc.
  • Circulite, Inc.
  • Cleveland Heart, Inc.
  • Heartware
  • Thoratec Corporation
  • Teleflex Incorporated
  • SynCardia Systems
  • MyoCardioCare, Inc
  • Maquet Holding

第11章 分析師的投資機會展望

第12章 市場未來展望

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 54071

The demand for cardiac assist devices has increased in the last few years, as these devices help in the continuous flow of blood to the heart and require no mechanical bearings. It also acts as a bridge in transplant, are available in miniature sizes, and are the life-line support for heart patients, assisting them in in recovering from or while waiting for a heart transplant. In March 2015, the US FDA approved the Impella 2.5 System, which helps the patients in maintaining a stable heart function and circulation, during certain high-risk percutaneous coronary intervention (HRPCI) procedures. The variety of reliable ventricular assist devices (VAD) has increased, as technology has advanced, promising better treatment options for patients. In addition, the government support has also increased the funding for research and development initiatives in advanced medical treatment options, placing utmost concern to the safety of patients.

Other factors such as rising geriatric population and increasing heart diseases prevalence are expected to drive the market in the forecast period.

Key Market Trends

Total Artificial Heart Segment is Expected to Show Better Growth in the Forecast Years

Based on product, it is segmented into Intra-aortic Balloon Pump, Total Artificial Heart, and Ventricular Assist Device. Heart transplantation is the most effective treatment for end-stage heart failures. Globally, there has been an increase in the demand for donor organs. According to the United States Department of Health and Human Services, there were approximately 17,553 donors in 2018. Moreover, there has been an exponential rise in the demand for artificial hearts in the market. It is estimated that nearly 4,000 individuals wait for a donor's heart daily in the United States alone. The total artificial heart is considered a long-term solution for patients suffering from advanced heart failure issues. There are currently, many different types of artificial hearts in the market that are being used: SynCardia temporary total artificial heart and Abiocar artificial heart. Thus, the availability of these products is expected to drive the market, globally.

North America Dominates the Cardiac Assist Devices Market

North America region is among the major contributor in this market due to the advancements in technology, and the increasing burden of heart diseases. According to the Centers for Disease Control and Prevention (CDC), about 647,000 Americans die from heart disease each year. The increasing number of individuals with heart diseases leads to a higher demand. Over 30% of global LVAD implants are being performed in the United States, and the number of implants is increasing year by year. Hence, the high adoption rate for these devices is expected to increase the cardiac assist devices market significantly during the forecast.

Competitive Landscape

The global players in the cardiac assist devices market are - Abbott Laboratories, Abiomed Inc., Berlin Heart GmbH, BiVACOR Inc., Braile Biomedica Ltd, Getinge AB, Jarvik Heart Inc., Medtronic PLC, SynCardia Systems, LLC, and Teleflex Incorporated.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Heart Disease Prevalence
    • 4.2.2 Rising Geriatric Population
    • 4.2.3 Technological Advancement
  • 4.3 Market Restraints
    • 4.3.1 Availability of Alternative Treatments like Pacemakers
    • 4.3.2 Risk Associated with Device Implantation
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Intra-aortic Balloon Pump
    • 5.1.2 Total Artificial Heart
    • 5.1.3 Ventricular Assist Device
      • 5.1.3.1 Left Ventricular Assist Device
      • 5.1.3.2 Right Ventricular Assist Device
  • 5.2 Geography
    • 5.2.1 North America
      • 5.2.1.1 United States
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 United Kingdom
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia-Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South Korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle-East and Africa
      • 5.2.4.1 GCC
      • 5.2.4.2 South Africa
      • 5.2.4.3 Rest of Middle-East and Africa
    • 5.2.5 South America
      • 5.2.5.1 Brazil
      • 5.2.5.2 Argentina
      • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Abiomed Inc.
    • 6.1.3 Berlin Heart GmbH
    • 6.1.4 BiVACOR Inc.
    • 6.1.5 Braile Biomedica Ltd
    • 6.1.6 Getinge AB
    • 6.1.7 Jarvik Heart Inc.
    • 6.1.8 Medtronic PLC
    • 6.1.9 SynCardia Systems, LLC
    • 6.1.10 Teleflex Incorporated

7 MARKET OPPORTUNITIES AND FUTURE TRENDS